Xia X - Search Results

1

Cell membrane-anchored and tumor-targeted IL-12 (attIL12)-T cell therapy for eliminating large and heterogeneous solid tumors.

Hu J, Yang Q, Zhang W, Du H, Chen Y, Zhao Q, Dao L, Xia X, Natalie Wall F, Zhang Z, Mahadeo K, Gorlick R, Kopetz S, Dotti G, Li S. Hu J, et al. Among authors: xia x. J Immunother Cancer. 2022 Jan;10(1):e003633. doi: 10.1136/jitc-2021-003633. J Immunother Cancer. 2022. PMID: 35027427 Free PMC article.

2

Regression of tumor growth and induction of long-term antitumor memory by interleukin 12 electro-gene therapy.

Li S, Zhang X, Xia X. Li S, et al. Among authors: xia x. J Natl Cancer Inst. 2002 May 15;94(10):762-8. doi: 10.1093/jnci/94.10.762. J Natl Cancer Inst. 2002. PMID: 12011227

3

Candidate genes associated with tumor regression mediated by intratumoral IL-12 electroporation gene therapy.

Li S, Xia X, Mellieon FM, Liu J, Steele S. Li S, et al. Among authors: xia x. Mol Ther. 2004 Mar;9(3):347-54. doi: 10.1016/j.ymthe.2003.11.022. Mol Ther. 2004. PMID: 15006601 Free article.

4

Stat1 deficiency in the host enhances interleukin-12-mediated tumor regression.

Torrero MN, Xia X, Henk W, Yu S, Li S. Torrero MN, et al. Among authors: xia x. Cancer Res. 2006 Apr 15;66(8):4461-7. doi: 10.1158/0008-5472.CAN-05-3554. Cancer Res. 2006. PMID: 16618773 Free article.

5

The mechanism of exogenous B7.1-enhanced IL-12-mediated complete regression of tumors by a single electroporation delivery.

Liu J, Xia X, Torrero M, Barrett R, Shillitoe EJ, Li S. Liu J, et al. Among authors: xia x. Int J Cancer. 2006 Nov 1;119(9):2113-8. doi: 10.1002/ijc.22100. Int J Cancer. 2006. PMID: 16823840

6

Administering plasmid DNA encoding tumor vessel-anchored IFN-alpha for localizing gene product within or into tumors.

Craig R, Cutrera J, Zhu S, Xia X, Lee YH, Li S. Craig R, et al. Among authors: xia x. Mol Ther. 2008 May;16(5):901-6. doi: 10.1038/mt.2008.40. Epub 2008 Mar 18. Mol Ther. 2008. PMID: 18388923 Free article.

7

Expression of WSX1 in tumors sensitizes IL-27 signaling-independent natural killer cell surveillance.

Dibra D, Cutrera JJ, Xia X, Birkenbach MP, Li S. Dibra D, et al. Among authors: xia x. Cancer Res. 2009 Jul 1;69(13):5505-13. doi: 10.1158/0008-5472.CAN-08-4311. Epub 2009 Jun 23. Cancer Res. 2009. PMID: 19549909 Free PMC article.

8

Discovery of a linear peptide for improving tumor targeting of gene products and treatment of distal tumors by IL-12 gene therapy.

Cutrera J, Dibra D, Xia X, Hasan A, Reed S, Li S. Cutrera J, et al. Among authors: xia x. Mol Ther. 2011 Aug;19(8):1468-77. doi: 10.1038/mt.2011.38. Epub 2011 Mar 8. Mol Ther. 2011. PMID: 21386825 Free PMC article.

9

WSX1 expression in tumors induces immune tolerance via suppression of effector immune cells.

Dibra D, Cutrera J, Xia X, Li S. Dibra D, et al. Among authors: xia x. PLoS One. 2011 Apr 29;6(4):e19072. doi: 10.1371/journal.pone.0019072. PLoS One. 2011. PMID: 21559505 Free PMC article.

10

Sonoporation delivery of interleukin-27 gene therapy efficiently reduces prostate tumor cell growth in vivo.

Zolochevska O, Xia X, Williams BJ, Ramsay A, Li S, Figueiredo ML. Zolochevska O, et al. Among authors: xia x. Hum Gene Ther. 2011 Dec;22(12):1537-50. doi: 10.1089/hum.2011.076. Epub 2011 Sep 1. Hum Gene Ther. 2011. PMID: 21801027 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,007 results

Search Page

Filters